Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management
Current Obesity Reports · 11.01.2025 · 14 (1)
DOI: 10.1007/s13679-024-00597-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Obesity Reports, online erschienen am 11.01.2025. Verfasst von Daniel Simancas-Racines und 7 weiteren Autor:innen. Beteiligte Einrichtung: Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Quito, 1…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Obesity, Dietary Supplements, Diet, Mediterranean. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
PURPOSE OF REVIEW: This narrative review explores the role of Medical Nutritional Therapy (MNT) in managing Metabolic-Associated Steatotic Liver Disease (MASLD), previously known as nonalcoholic fatty liver disease. It aims to examine the effectiveness of specific nutritional strategies in preventing and treating this obesity-linked liver disease. RECENT FINDINGS: Emerging evidence underscores the benefits of the Mediterranean diet, low-carbohydrate diets, and intermittent fasting in reducing liver fat, improving insulin sensitivity, and mitigating inflammation. Supplementing with vitamin E, omega-3 fatty acids, and silymarin can potentially reduce liver fibrosis and promote liver health. MNT is a key intervention for MASLD management, emphasizing dietary patterns, caloric restriction, and nutraceutical supplementation. Integrating these strategies with lifestyle modifications, including regular physical activity, offers a comprehensive approach to improving metabolic and liver outcomes in patients with MASLD. Further research is needed to refine and personalize these therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Quito, 170527, Ecuador. dsimancas@ute.edu.ec.
- Facoltà di Scienze Umane, della Formazione e dello Sport, Università Telematica Pegaso, Via Porzio, Centro Direzionale, Isola F2, Naples, 80143, Italy.
- Department of Public Health, University of Naples Federico II, Naples, Italy.
- Gastroenterology Unit, Ospedale Dell'Angelo, Venice, Italy.
- Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Quito, 170527, Ecuador.
- Unità di Endocrinologia, Diabetologia e Andrologia, Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131, Naples, Italy.
Zitieren
APA
Simancas-Racines, D., Annunziata, G., Verde, L., Fascì-Spurio, F., Reytor-González, C., Muscogiuri, G., Frias-Toral, E., & Barrea, L. (2025). Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management. Current Obesity Reports, 14(1). https://doi.org/10.1007/s13679-024-00597-6
Vancouver
Simancas-Racines D, Annunziata G, Verde L, Fascì-Spurio F, Reytor-González C, Muscogiuri G, et al. Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management. Current Obesity Reports. 2025;14(1). doi:10.1007/s13679-024-00597-6
BibTeX
@article{SimancasRacines2025,
author = {Simancas-Racines, Daniel and Annunziata, Giuseppe and Verde, Ludovica and Fascì-Spurio, Federica and Reytor-González, Claudia and Muscogiuri, Giovanna and Frias-Toral, Evelyn and Barrea, Luigi},
title = {Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management},
journal = {Current Obesity Reports},
year = {2025},
volume = {14},
number = {1},
doi = {10.1007/s13679-024-00597-6}
}
EUVIMED